Zevra Therapeutics Inc
NASDAQ:ZVRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zevra Therapeutics Inc
NASDAQ:ZVRA
|
US |
|
M
|
MKS Instruments Inc
XMUN:MKT
|
US |
|
B
|
Bank of Nova Scotia
SWB:BKN
|
CA |
|
W
|
Wells Fargo & Co
XBER:NWT
|
US |
|
A
|
American Water Works Company Inc
XBER:AWC
|
US |
Wall St Price Targets
ZVRA Price Targets Summary
Zevra Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for ZVRA is 28.815 USD with a low forecast of 21.21 USD and a high forecast of 36.75 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZVRA's stock price target?
Price Target
28.815
USD
According to Wall Street analysts, the average 1-year price target for ZVRA is 28.815 USD with a low forecast of 21.21 USD and a high forecast of 36.75 USD.
What is the Revenue forecast for Zevra Therapeutics Inc?
Projected CAGR
22%
The compound annual growth rate for Revenue over the next 8 years is 22%.
What is the Gross Profit forecast for Zevra Therapeutics Inc?
Projected CAGR
21%
The compound annual growth rate for Gross Profit over the next 8 years is 21%.
What is the Pre-Tax Income forecast for Zevra Therapeutics Inc?
Projected CAGR
19%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.
What is the Net Income forecast for Zevra Therapeutics Inc?
Projected CAGR
19%
The compound annual growth rate for Net Income over the next 8 years is 19%.
